YIH
VNDA icon

Y-Intercept (HK)’s Vanda Pharmaceuticals VNDA Stock Holding History

Y-Intercept (HK)’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.8M Buy
+294,131
New +$1.92M 0.04% 758
2024
Q3 		– Sell
-10,594
Closed -$59.9K – 1842
2024
Q2 		$59.9K Buy
+10,594
New +$54.7K ﹤0.01% 1290
2023
Q4 		– Sell
-162,475
Closed -$702K – 1679
2023
Q3 		$702K Buy
+162,475
New +$903K 0.07% 434
2023
Q2 		– Sell
-42,743
Closed -$290K – 1756
2023
Q1 		$290K Sell
42,743
-15,338
-26% -$108K 0.03% 791
2022
Q4 		$429K Buy
+58,081
New +$566K 0.06% 491

Other funds holding VNDA

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.6B AUM 29.42% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
CFS
CGC Financial Services Lake Oswego, Oregon $445M AUM 17.73% 1-Year Est. Return